Universität Innsbruck & Medizinische Universität Innsbruck

CCB Lecture Series 2026/27

Epige­netic Control of Fore­brain Inhi­bi­tory Neuron Deve­lop­ment and Its Disrup­tion in Psychia­tric Disor­ders

Gastvortrag
Montag, 16. November 2026, 17:00 – 18:00 ical

CHRIS­TIAN MAYER
Max Planck Insti­tute for Biolo­gical Intel­li­gence, Martins­ried

Sprecher "Christian Mayer" ist auf dem Bild zu sehen

Christian studies how the remarkable diversity of inhibitory neurons in the forebrain emerges during development. After training in Hamburg, he was a postdoc in Gord Fishell’s lab at NYU and the Broad Institute, where he was among the first to apply single-cell RNA sequencing to developing interneurons. That work showed that cardinal interneuron classes are already specified in the embryonic ganglionic eminences and identified Mef2c, a gene linked to neurodevelopmental disorders, as essential for parvalbumin interneuron development. Since 2018 he has led the Max Planck Research Group “Neurogenomics,” supported by an ERC Starting Grant. His lab has developed in vivo barcoding approaches that combine clonal lineage tracing with single-cell transcriptomics (Nature 2022), and has shown that spatially restricted enhancer activity in progenitors shapes inhibitory neuron identity (Nature Neuroscience 2024). His lab combines genetic fate mapping, single-cell and spatial genomics, and computational methods to understand how enhancers, transcription factors, and chromatin regulators shape neuronal identity. In his talk, “Epigenetic Control of Forebrain Inhibitory Neuron Development and Its Disruption in Psychiatric Disorders,” he will describe how epigenetic mechanisms guide inhibitory neurons from progenitor to mature cell type, and how disruption of these programs may contribute to autism, schizophrenia, and related conditions.

CCB
Innrain 80, Raum: M01.490 / M01.470
6020 Innsbruck

Teilnahme

Eintritt frei

Veranstalter

Medizinische Universität Innsbruck / Biozentrum Innsbruck

PDFs und Links

Flyer

  • Nach oben scrollen